10D 2. Steroids and the male reproductive system—II 362. Sertoli cell production of testicular androgen binding protein (ABP)

The influence of pharmaceutical compounds on male fertility

1. Steroid hormones can affect spermatogenesis and thereby fertility directly and/or indirectly. All antigonadotropically active steroids inhibit spermatogenesis via inhibition of gonadotropin secretion, mainly that of H. Androgens and steroids occurring in the biosynthetic chain of testosterone synthesis have a direct promoting effect on spermatogenesis if applied in high doses. It has not been possible as yet to make clinical use of this positive effect since it is obviously not possible to achieve the necessary intratesticular androgen concentrations. 2. As concerns the different androgens and the steroids in the androgen biosynthetic chain, and also all synthetic anabolics, there is no parallelism between the direct spermatogenic activity, the androgenic activity and the antigonadotropic activity. 3. Estrogens and synthetic gestagens do not inhibit spermatogenesis directly at the testicular level. All effects of estrogens can be abolished experimentally by adequate substitution with gonadotropins or androgens, or a combination of androgens and gonadotropins. 4. Only those antiandrogens inhibit spermatogenesis with additional antigonadotropic properties (e.g. cyproterone acetate). Pure antiandrogens, like flutamide or cyproterone, have a slight and transient influence on spermatogenesis at the most. If at all, they merely cause transient subfertility. 5. Beside steroids and several centrally active pharmaceutics (e.g. psychotropic drugs and several antihypertensive compounds), only siloxanes and methallibur seem to affect spermatogenesis via inhibition of gonadotropin secretion. Other antispermatogenic agents act by inhibition of mitosis (Colchicine, alkylating agents) or presumably via damage of the Sertoli cells. 6. Based on present knowledge, contraception in men could be principally managed by administration of a) androgens alone, b) gestagen/androgen combinations, c) estrogen/androgen combinations, d) certain antiandrogens. 7. The difficulties of contraception in men by steroid hormones or steroid hormone combinations have been pointed out. As regards the usefulness of antiandrogens for contraception, no definite conclusions can be drawn at the moment. All non-steroidal inhibitors of spermatogenesis which have been found up to the present are not suitable because of toxic effects.

Preliminary characterization of a new androgen-binding protein in human seminal plasma

In order to obtain comparative analysis between the steroid binding proteins from blood serum and seminal plasma, fresh samples were incubated and assayed in parallel with the following tritiated steroids: dihydrotestosterone, testosterone, cortisol, progesterone and estradiol. Thereafter, and using techniques such as (1) polyacrilamide disk gel electrophoresis with elution of proteins from the gel slices, (2) ammonium sulphate precipitation, (3) enzymatic hydrolysis, and (4) gel filtration on Sephadex G-100, there was a resemblance in the electrophoretic patterns confirming the presence in both fluids of proteins like TeBG, CBG, and Albumin, previously described in blood serum. In seminal fluid, but not in blood serum, another small protein with androgen binding capacity was found and its preliminary characterization demonstrated: disappearance with enzymatic treatment, low molecular weight, negative charge, and precipitation range with ammonium sulphate from 30 to 35%. Its elution profile on Sephadex G-100 was contaminated with albumin.